5 results for "Soni, Prashant"
Showing 1–5 · 0.49 seconds · RSS
-
Journal Article Full text
Birth Asphyxia: Risk Factors, Complications, and Outcomes in Neonates Admitted at a Tertiary Care Center in Gujarat, India
Background Birth asphyxia is a significant cause of neonatal morbidity and mortality, especially in low- and middle-income countries. It is often associated with long-term neurological and systemic complications. This study explores the incidence, maternal and neonatal risk factors, and outcomes of…
-
Journal Article Full text
RNA-seq data of control and powdery mildew pathogen (Golovinomyces orontii) treated transcriptomes of Helianthus niveus
Identification of genes expressed during the Golovinomyces orontii infection process in Helianthus niveus assumes importance for incorporation of resistance to powdery mildew in cultivated sunflower (H. annuus L.) from this donor species. RNA-seq analysis of control (uninfected) and infected…
-
Journal Article Full text
P-1184. Efficacy and Safety of Imipenem/Cilastatin/Relebactam (IMI/REL) in Treating Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia: A Systematic Literature Review of Randomized Control Trials
…I work for a consultancy that contracts with Pharma companies Prashant Soni, Masters in Pharmacy, BMS: I work in a consultancy that contracts with Pharma companies|Merck: I work in a consultancy that contracts with Pharma companies|Pfizer: I work in a consultancy that contracts with Pharma…
-
Journal Article Full text
Exploring the Effectiveness of Imipenem/Relebactam in Patients with Antimicrobial-Resistant Hospital-Acquired Infections: Findings from Systematic Literature Reviews
Introduction: Infections attributed to multidrug-resistant organisms have resulted in a significant clinical burden, high mortality, and excessive costs. Identifying the most appropriate and efficacious treatments will aid in reducing these burdens. Imipenem/cilastatin + relebactam (I/R) is used…